In our report, we illustrated that the expression of LOXL2 in GC tissues was higher than that in normal tissues, and this expression was markedly correlated with tumor stage and poor OS in patients with GC, which was consistent with reports above. This evidence concerns the gene LOXL2 and gastric cancer.